Rapporten

Dybdegående analyser af virksomhedsfinansiering, vækststrategier og markedsindsigt fra verdens mest innovative virksomheder

3 rapporter og tæller

Opdateret dagligt med den seneste markedsintelligens

Abcuro Raises $200M in Series C

Abcuro, a HealthTech company based in Cambridge, MA, has raised $200M in Series C at a $1.5B valuation led by RA Capital, Arch Venture Partners.

Fundraising News Team

Abcuro raises $200M Series C at $1.5B valuation

Abcuro raises $200M in Series C at $1.5B valuation. Antibody therapeutics for autoimmune diseases...

0 min read•$200M

Abcuro Raises $200M Series C to Transform Biotech

Abcuro has secured $200M Series C in funding to accelerate growth and innovation in the biotech sector. Precision oncology company discovering and developing novel cancer immunotherapies targeting tumor microenvironments...

0 min read•$200M Series C

Side 1

Viser 3 rapporter • Side 1 • Kategori: all

Hold dig foran markedet

Få ugentlig indsigt leveret til din indbakke. Ingen spam, kun intelligens.